James W. Liken - 22 Jan 2024 Form 4 Insider Report for VAPOTHERM INC

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Sep 2024, 15:16:55 UTC
Prior SEC filing
03 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James A. Lightman, as Attorney In Fact

Key filing fact

James W. Liken filed Form 4 for VAPOTHERM INC on 24 Sep 2024.

Key facts

  • This page summarizes James W. Liken's Form 4 filing for VAPOTHERM INC.
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 24 Sep 2024, 15:16.

Change

  • Previous filing in this sequence was filed on 03 Jan 2024.
  • Current net transaction value: -$135,438.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VAPO transaction

Common Stock

Sale

Transaction value
$15,956
Shares
-17,500
Change %
-26%
Price
$0.9118
Shares after
50,308
Date
22 Jan 2024
Ownership
Direct
Footnotes
F1
VAPO transaction

Common Stock

Disposed to Issuer

Transaction value
$109,671
Shares
-50,308
Change %
-100%
Price
$2.18
Shares after
0
Date
20 Sep 2024
Ownership
Direct
Footnotes
F2
VAPO transaction

Common Stock

Disposed to Issuer

Transaction value
$9,810
Shares
-4,500
Change %
-100%
Price
$2.18
Shares after
0
Date
20 Sep 2024
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VAPO transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-1,187
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,187
Exercise price
$150.00
Footnotes
F4
VAPO transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-1,089
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,089
Exercise price
$18.48
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.92, inclusive. The reporting person undertakes to provide to Vapotherm, Inc. (Company), any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Footnote F2

Disposed of pursuant to an Agreement and Plan of Merger, dated as of June 17, 2024, among Veronica Holdings, LLC, Veronica Intermediate Holdings, LLC, Veronica Merger Sub, Inc. and the Company, in exchange for a cash payment of $2.18 per share.

Footnote F3

The restricted stock unit awards, which these shares were subject to, were canceled in the merger in exchange for a cash payment of $2.18 per underlying share.

Footnote F4

This option, which provided for vesting in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2020 annual meeting of stockholders, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.

Footnote F5

This option, which provided for vesting in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2023 annual meeting of stockholders, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .